Erlotinib or best supportive care for third-line treatment of advanced non-small-cell lung cancer: A real-world cost-effectiveness analysis

DOI Web Site Web Site 被引用文献3件

収録刊行物

  • Lung Cancer

    Lung Cancer 76 (3), 472-477, 2012-06

    Elsevier BV

被引用文献 (3)*注記

もっと見る

問題の指摘

ページトップへ